Clinical Trials
486 trialsCryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
Psoriasis Treatment Center of Central New Jersey
The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs
Peking University Cancer Hospital & Institute
Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma
European Institute of Oncology
Microscopy Imaging of Whole-mount Stained Human Tissues
National Taiwan University Hospital
Trimelvax001
University of Chile
iToBoS
The University of Queensland
REDT-BCC
Maastricht University Medical Center
Mogamulizumab Q4week Dosing in Participants With R/R CTCL
Kyowa Kirin Co., Ltd.
NIVOPTIMIZE
Erasmus Medical Center
Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma
University of Colorado, Denver
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Northwestern University
Dermatoscopy Guided Resection for Skin Cancer
Region Örebro County
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
R-Pharm
POSITive
European Institute of Oncology
EvaLymph-Leg2
KU Leuven
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
CRISTINA
Russian Academy of Medical Sciences
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Sun Yat-sen University
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
Medical University of Vienna
SNMM
Eye & ENT Hospital of Fudan University
Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy
Odense University Hospital
Uveal Melanoma - Comparative Study
Medical University of Vienna
Identification of Oral Lesions Through an Autofluorescence System
Federico II University
MELCAYA
Azienda Ospedaliera di Perugia
ECOBASO
Damae Medical
Remote Assessment of OCT Scans for BCC Detection
Maastricht University Medical Center
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
RemeGen Co., Ltd.
AI-aided Optical Coherence Tomography for the Detection of Basal Cell Carcinoma
Maastricht University Medical Center
cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study
Maastricht University Medical Center
Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App
Herlev Hospital
BMUMM
Centre Hospitalier Universitaire de Nice
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
TopAlliance Biosciences
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
JS InnoPharm, LLC
MINI-MD
University Hospital Rijeka
Skin Tumor Biomarkers by Mass Spectrometry Imaging
Bispebjerg Hospital
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
M.D. Anderson Cancer Center
Melanoma
University of California, Davis
Shadow4All
Universidade do Porto
Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients
Institute of Oncology Ljubljana
CELEBRATE
Peter MacCallum Cancer Centre, Australia
The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
University of Aleppo
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
ACTME
Leiden University Medical Center
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Provectus Pharmaceuticals
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
University Hospital, Basel, Switzerland
Negative-pressure Wound Therapy on Full-thickness Skin Grafts of the Lower Leg
Helsinki University Central Hospital
New Treatments for Actinic Keratoses of the Scalp
Helsinki University Central Hospital
OpACIN-neo
The Netherlands Cancer Institute